The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing male and/or female non-hormonal contraception development with the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism, fertility studies).
The purpose of this FOA is to provide investigators with a mechanism to request services from this facility that would advance their development program for either male or female contraceptives.
- Letter of Intent Due Date(s): 30 days before application due date.
- Application Due Date(s): July 1, 2019, December 16, 2019, May 1, 2020, December 15, 2020, May 3, 2021, and December 13, 2021
PAR-19-261 Expiration Date December 14, 2021